1. Home
  2. CNXN vs IVA Comparison

CNXN vs IVA Comparison

Compare CNXN & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNXN

PC Connection Inc.

N/A

Current Price

$60.49

Market Cap

1.5B

ML Signal

N/A

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

N/A

Current Price

$6.52

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNXN
IVA
Founded
1982
2011
Country
United States
France
Employees
N/A
84
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
CNXN
IVA
Price
$60.49
$6.52
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$16.20
AVG Volume (30 Days)
64.5K
381.5K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
3.27
N/A
Revenue
N/A
N/A
Revenue This Year
$6.24
N/A
Revenue Next Year
$4.39
N/A
P/E Ratio
$18.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.97
$2.70
52 Week High
$71.17
$7.98

Technical Indicators

Market Signals
Indicator
CNXN
IVA
Relative Strength Index (RSI) 46.61 57.06
Support Level $58.57 $5.79
Resistance Level $62.42 $7.17
Average True Range (ATR) 1.55 0.31
MACD -0.24 -0.04
Stochastic Oscillator 40.40 54.43

Price Performance

Historical Comparison
CNXN
IVA

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: